Article
What's new in regenerative medicine: split up of the mesenchymal stem cell family promises new hope for cardiovascular repair.
Journal of cardiovascular translational research - 1 Oct 2012
Vono Rosa, Spinetti Gaia, Gubernator Miriam, Madeddu Paolo
Abstract excerpt
Coronary artery disease (CAD) is exceedingly prevalent and requires care optimization. Regenerative medicine holds promise to improve the clinical outcome of CAD patients. Current approach consists in subsidizing the infarcted heart with boluses of autologous stem cells from the bone marrow. Moreover, mesenchymal stem cells (MSCs) are in the focus of intense research owing to an apparent superiority in plasticity...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
